163 results
8-K
EX-99.1
FGEN
FibroGen Inc
6 May 24
FibroGen Reports First Quarter 2024 Financial Results
4:05pm
for the treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis. Roxadustat is in clinical development for chemotherapy
8-K
EX-99.1
FGEN
FibroGen Inc
26 Feb 24
FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
4:08pm
in China, Europe, Japan, and numerous other countries for the treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis
8-K
EX-99.1
v1r6nuspc1f6s1r 3i
6 Nov 23
FibroGen Reports Third Quarter 2023 Financial Results
4:05pm
8-K
EX-99.1
d02o392kzr onh
7 Aug 23
FibroGen Reports Second Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
yftj532 etjzcl
26 Jun 23
FibroGen Announces Topline Results from Phase 3 ZEPHYRUS-1 Study of Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis
9:05am
8-K
EX-99.1
fqw6m2ko0ty0 1iz0
8 May 23
FibroGen Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
k2qbjlfgfkl
7 Nov 22
FibroGen Reports Third Quarter 2022 Financial Results
4:06pm
S-3ASR
EX-1.2
qtu mnb7llvkffy
8 Aug 22
Automatic shelf registration
5:12pm
S-3ASR
l8k4or71zz k5
8 Aug 22
Automatic shelf registration
5:12pm